Copyright Reports & Markets. All rights reserved.

Global Orally Disintegrating Tablet Market Growth 2019-2024

Request for Sample of this report
Buy now

Table of Contents

    2019-2024 Global Orally Disintegrating Tablet Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Orally Disintegrating Tablet Consumption 2014-2024
        • 2.1.2 Orally Disintegrating Tablet Consumption CAGR by Region
      • 2.2 Orally Disintegrating Tablet Segment by Type
        • 2.2.1 Anti-Psychotics Drug
        • 2.2.2 Anti-Epileptics Drug
        • 2.2.3 Other
      • 2.3 Orally Disintegrating Tablet Consumption by Type
        • 2.3.1 Global Orally Disintegrating Tablet Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Orally Disintegrating Tablet Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Orally Disintegrating Tablet Sale Price by Type (2014-2019)
      • 2.4 Orally Disintegrating Tablet Segment by Application
        • 2.4.1 CNS Diseases
        • 2.4.2 Gastrointestinal Diseases
        • 2.4.3 CVS Diseases
        • 2.4.4 Other
      • 2.5 Orally Disintegrating Tablet Consumption by Application
        • 2.5.1 Global Orally Disintegrating Tablet Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Orally Disintegrating Tablet Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Orally Disintegrating Tablet Sale Price by Application (2014-2019)

      3 Global Orally Disintegrating Tablet by Players

      • 3.1 Global Orally Disintegrating Tablet Sales Market Share by Players
        • 3.1.1 Global Orally Disintegrating Tablet Sales by Players (2017-2019)
        • 3.1.2 Global Orally Disintegrating Tablet Sales Market Share by Players (2017-2019)
      • 3.2 Global Orally Disintegrating Tablet Revenue Market Share by Players
        • 3.2.1 Global Orally Disintegrating Tablet Revenue by Players (2017-2019)
        • 3.2.2 Global Orally Disintegrating Tablet Revenue Market Share by Players (2017-2019)
      • 3.3 Global Orally Disintegrating Tablet Sale Price by Players
      • 3.4 Global Orally Disintegrating Tablet Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Orally Disintegrating Tablet Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Orally Disintegrating Tablet Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Orally Disintegrating Tablet by Regions

      • 4.1 Orally Disintegrating Tablet by Regions
        • 4.1.1 Global Orally Disintegrating Tablet Consumption by Regions
        • 4.1.2 Global Orally Disintegrating Tablet Value by Regions
      • 4.2 Americas Orally Disintegrating Tablet Consumption Growth
      • 4.3 APAC Orally Disintegrating Tablet Consumption Growth
      • 4.4 Europe Orally Disintegrating Tablet Consumption Growth
      • 4.5 Middle East & Africa Orally Disintegrating Tablet Consumption Growth

      5 Americas

      • 5.1 Americas Orally Disintegrating Tablet Consumption by Countries
        • 5.1.1 Americas Orally Disintegrating Tablet Consumption by Countries (2014-2019)
        • 5.1.2 Americas Orally Disintegrating Tablet Value by Countries (2014-2019)
      • 5.2 Americas Orally Disintegrating Tablet Consumption by Type
      • 5.3 Americas Orally Disintegrating Tablet Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Orally Disintegrating Tablet Consumption by Countries
        • 6.1.1 APAC Orally Disintegrating Tablet Consumption by Countries (2014-2019)
        • 6.1.2 APAC Orally Disintegrating Tablet Value by Countries (2014-2019)
      • 6.2 APAC Orally Disintegrating Tablet Consumption by Type
      • 6.3 APAC Orally Disintegrating Tablet Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Orally Disintegrating Tablet by Countries
        • 7.1.1 Europe Orally Disintegrating Tablet Consumption by Countries (2014-2019)
        • 7.1.2 Europe Orally Disintegrating Tablet Value by Countries (2014-2019)
      • 7.2 Europe Orally Disintegrating Tablet Consumption by Type
      • 7.3 Europe Orally Disintegrating Tablet Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Orally Disintegrating Tablet by Countries
        • 8.1.1 Middle East & Africa Orally Disintegrating Tablet Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Orally Disintegrating Tablet Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Orally Disintegrating Tablet Consumption by Type
      • 8.3 Middle East & Africa Orally Disintegrating Tablet Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Orally Disintegrating Tablet Distributors
      • 10.3 Orally Disintegrating Tablet Customer

      11 Global Orally Disintegrating Tablet Market Forecast

      • 11.1 Global Orally Disintegrating Tablet Consumption Forecast (2019-2024)
      • 11.2 Global Orally Disintegrating Tablet Forecast by Regions
        • 11.2.1 Global Orally Disintegrating Tablet Forecast by Regions (2019-2024)
        • 11.2.2 Global Orally Disintegrating Tablet Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Orally Disintegrating Tablet Forecast by Type
      • 11.8 Global Orally Disintegrating Tablet Forecast by Application

      12 Key Players Analysis

      • 12.1 Teva
        • 12.1.1 Company Details
        • 12.1.2 Orally Disintegrating Tablet Product Offered
        • 12.1.3 Teva Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Teva News
      • 12.2 Merck
        • 12.2.1 Company Details
        • 12.2.2 Orally Disintegrating Tablet Product Offered
        • 12.2.3 Merck Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Merck News
      • 12.3 Mylan
        • 12.3.1 Company Details
        • 12.3.2 Orally Disintegrating Tablet Product Offered
        • 12.3.3 Mylan Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 Mylan News
      • 12.4 Pfizer
        • 12.4.1 Company Details
        • 12.4.2 Orally Disintegrating Tablet Product Offered
        • 12.4.3 Pfizer Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Pfizer News
      • 12.5 Johnson and Johnson
        • 12.5.1 Company Details
        • 12.5.2 Orally Disintegrating Tablet Product Offered
        • 12.5.3 Johnson and Johnson Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Johnson and Johnson News
      • 12.6 GSK
        • 12.6.1 Company Details
        • 12.6.2 Orally Disintegrating Tablet Product Offered
        • 12.6.3 GSK Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 GSK News
      • 12.7 Otsuka
        • 12.7.1 Company Details
        • 12.7.2 Orally Disintegrating Tablet Product Offered
        • 12.7.3 Otsuka Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Otsuka News
      • 12.8 Eli Lilly and Company
        • 12.8.1 Company Details
        • 12.8.2 Orally Disintegrating Tablet Product Offered
        • 12.8.3 Eli Lilly and Company Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 Eli Lilly and Company News
      • 12.9 AstraZeneca
        • 12.9.1 Company Details
        • 12.9.2 Orally Disintegrating Tablet Product Offered
        • 12.9.3 AstraZeneca Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 AstraZeneca News
      • 12.10 Bristol-Myers Squibb
        • 12.10.1 Company Details
        • 12.10.2 Orally Disintegrating Tablet Product Offered
        • 12.10.3 Bristol-Myers Squibb Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.10.4 Main Business Overview
        • 12.10.5 Bristol-Myers Squibb News
      • 12.11 Conquer

      13 Research Findings and Conclusion

      An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
      The classification of Orally Disintegrating Tablet includes Anti-Psychotics Drug, Anti-Epileptics Drug and others, and the proportion of Anti-Psychotics Drug in 2017 is about 16.6%, Anti-Psychotics drug class will be the reigning segment in terms of market revenue share throughout the forecast period, anticipated to hold about 20.3% revenue share of the global market by 2025 end. With a noteworthy 15.7% CAGR, this segment will retain its supremacy over other drug class segments during the eight-year period.
      Under by Disease Indication, the global market is segmented into Central Nervous System (CNS) Diseases, Gastrointestinal (GI) Diseases, Cardiovascular (CVS) Diseases and Others. CNS Diseases segment will hold maximum revenue share in the global market, and the consumption proportion is about 53.4% in 2017. and forecasts indicate a 57.2% market share for this segment by the end of the forecast period in 2025.
      North America is the largest consumption place, with a consumption market share nearly 40.5% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 31.6%, China is also an important sales region for the Orally Disintegrating Tablet.

      According to this study, over the next five years the Orally Disintegrating Tablet market will register a 11.3% CAGR in terms of revenue, the global market size will reach US$ 21300 million by 2024, from US$ 11200 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Orally Disintegrating Tablet business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares, and growth opportunities of Orally Disintegrating Tablet market by product type, application, key manufacturers and key regions and countries.

      This study considers the Orally Disintegrating Tablet value and volume generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
      Anti-Psychotics Drug
      Anti-Epileptics Drug
      Other
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
      CNS Diseases
      Gastrointestinal Diseases
      CVS Diseases
      Other

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      Teva
      Merck
      Mylan
      Pfizer
      Johnson and Johnson
      GSK
      Otsuka
      Eli Lilly and Company
      AstraZeneca
      Bristol-Myers Squibb
      Conquer

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Orally Disintegrating Tablet consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of Orally Disintegrating Tablet market by identifying its various subsegments.
      Focuses on the key global Orally Disintegrating Tablet manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Orally Disintegrating Tablet with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the consumption of Orally Disintegrating Tablet submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      Buy now